Skip to main content
Premium Trial:

Request an Annual Quote

EKF Diagnostics Looks to Sell POC Dx Business for $110M

NEW YORK (GenomeWeb) – EKF Diagnostics today announced that it has received a $110 million offer from an undisclosed buyer for its point-of-care diagnostics business.

The firm has received a non-binding preliminary proposal for the business, which excludes its clinical chemistry and molecular diagnostics businesses. The offer is one of the results from a strategic review initiated April 2 by the firm's board of directors.

The firm said that in the event the POC business is not sold, the strategic review recommends spinning off the molecular diagnostics division, including its biomarkers business, to create a new company with a focus on personalized medicine to be led by current board Chairman David Evans. In that event, EKF Diagnostics would invite shareholder Ron Zwanziger to join the board as chairman.

The firm said in a statement that, short of a sale, this would bring the most shareholder benefit by allowing earnings from POC diagnostics to be undiluted by investment and losses associated with the molecular diagnostics business.

The Scan

Foxtail Millet Pangenome, Graph-Based Reference Genome

Researchers in Nature Genetics described their generation of a foxtail millet pangenome, which they say can help in crop trait improvement.

Protein Length Distribution Consistent Across Species

An analysis in Genome Biology compares the lengths of proteins across more than 2,300 species, finding similar length distributions.

Novel Genetic Loci Linked to Insulin Resistance in New Study

A team reports in Nature Genetics that it used glucose challenge test data to home in on candidate genes involved in GLUT4 expression or trafficking.

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.